Upcoming Policies effective April 6, 2026
Natiijooyinka Raadinta
Soo bandhiga 4061 - 4070 ee natiijooyinka 4294
Bixiye
QP8-26 Commercial Pharmacy Benefit Exclusion for Exdensur, Ustekinumab-aauz, Vancomycin hcl
Taariikhda uu dhaqangalayo Barnaamijka: 11, Feb 2026
Bixiye
QP7-26 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: 11, Feb 2026
Bixiye
QP6-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective April 1, 2026
Taariikhda uu dhaqangalayo Barnaamijka: 11, Feb 2026
Bixiye
QP5-26 MHCP Pharmacy Benefit Exclusion for Exdensur and Rybrevant Faspro™
Taariikhda uu dhaqangalayo Barnaamijka: 11, Feb 2026